查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1838590

非酒精性脂肪性肝炎市场分析及预测（至2034年）：类型、产品、服务、技术、应用、最终用户、阶段、模式和解决方案

Non alcoholic Steatohepatitis Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Stage, Mode, Solutions
出版日期: | 出版商: Global Insight Services | 英文 354 Pages | 商品交期: 3-5个工作天内

价格
简介目录

非酒精性脂肪性肝炎市场预计将从 2024 年的 119 亿美元增加到 2034 年的 1,029 亿美元，复合年增长率约为 24.1%。非酒精性脂肪性肝炎 (NASH) 市场涵盖非酒精性脂肪堆积引起的肝臟发炎和损伤的治疗方案的开发和行销。该市场的发展受到肥胖率上升、久坐不动的生活方式以及人们对肝臟健康的认识不断提高的推动。该市场涵盖药物、诊断和生活方式干预，重点是创新治疗方法和早期检测方法。由于 NASH 可能发展为肝硬化和肝癌，对有效治疗方法的需求日益增长，从而推动了这一快速增长领域的研究和投资。

非酒精性脂肪性肝炎 (NASH) 市场预计将强劲扩张，这得益于人们日益增长的认知度和盛行率。在治疗领域，由于药物研发的进步，治疗领域预计将引领潮流。尤其是纤维化药物，预计将成为该领域表现最佳的药物，因为它们能够有效应对疾病进展的关键阶段。紧随其后的是诊断领域，该领域发展势头强劲，反映了人们对早期精准疾病检测的需求。影像技术和生物标记识别的创新正在提升诊断能力，使非侵入性治疗方案更具吸引力。随着整体 NASH 管理方法的兴起，专注于饮食和运动的生活方式管理细分领域也正在经历成长。製药公司之间的策略联盟和伙伴关係正在加速研发，进一步推动市场动态。随着对有效 NASH 解决方案的需求不断增长，相关人员正在增加对新型治疗和诊断创新的投资。

市场区隔
类型 生物标记、治疗药物、诊断药物
产品 药品、生技药品、营养补充品和医疗设备
服务 临床试验、咨询服务、病患支援服务和监管服务
科技 基因体学、蛋白质体学、生物资讯学、成像技术
目的 切片检查、影像检查和血液检查
最终用户 医院、诊所、科研院所、製药公司
阶段 临床前、I期、II期、III期
模式 侵入性、非侵入性
解决方案 治疗方案、诊断方案

市场概述

非酒精性脂肪性肝炎 (NASH) 市场的特点是市场环境充满活力，各大製药公司都占有相当大的市场份额。在创新治疗方案需求旺盛的推动下，定价策略依然竞争激烈。最近推出的产品引入了突破性的治疗方法，扩大了医疗保健提供者可用的治疗途径。这导致定价环境日益激烈，因为各公司透过差异化产品和策略联盟来争夺市场主导地位。市场研发投资激增，推动了候选药物的推出。竞争性基准基准化分析显示，NASH 市场竞争激烈，主要企业专注于策略併购以巩固其市场地位。法规具有重大影响，严格的指导方针决定了 NASH 疗法的核准和商业化。北美和欧洲的监管环境尤其具有影响力，为临床疗效和安全性设定了高标准。这些严格的法规，加上病人意识的提高，正在推动市场变革。新兴生技公司推出创新治疗方法，进而重塑市场动态，进一步加剧了竞争格局。

主要趋势和驱动因素：

由于肥胖和第 2 型糖尿病的盛行率不断上升，非酒精性脂肪性肝炎 (NASH) 市场正在经历显着增长。这些疾病是 NASH 的主要风险因素，并推动了对有效治疗的需求。一个关键趋势是开发针对疾病进展中涉及的特定途径的新型疗法。製药公司正在投资研究，以发现可以阻止或逆转肝损伤的创新药物。提高对肝臟健康和早期诊断的认识也在推动市场成长。医疗保健提供者正在强调筛检和早期疗育的重要性，从而提高患者的参与度。此外，诊断技术的进步使得 NASH 检测方法更加准确和非侵入性。监管支持和对有前景的治疗方法的加快核准流程正在进一步加速市场扩张。全球对个人化医疗的关注为客製化治疗方法创造了机会，以改善患者的预后。随着我们对 NASH 病理生理学的理解不断加深，市场已准备好迎接创新进步和有利可图的商机。

限制与挑战：

非酒精性脂肪性肝炎 (NASH) 市场面临几个重大的限制和挑战。一个关键的挑战是准确诊断 NASH 的复杂性，这通常需要侵入性肝臟切片检查，这对患者来说既昂贵又有风险。这种诊断的复杂性限制了早期发现和早期疗育，阻碍了市场成长。另一个限制因素是缺乏专门针对 NASH 的核准治疗方法，迫使人们依赖仿单标示外治疗。缺乏标靶治疗限制了治疗选择和市场扩张。此外，持续研发的高成本造成了经济负担，阻碍了中小企业进入市场。另一个挑战是患者之间病情进展的差异，这使得临床试验设计和结果变得复杂。最后，医疗专业人员和患者普遍缺乏对 NASH 的认识和了解，这阻碍了早期诊断和治疗，最终抑制了市场成长。

关键人物

Intercept Pharmaceuticals、Genfit、Madrigal Pharmaceuticals、Galmed Pharmaceuticals、Viking Therapeutics、Akero Therapeutics、89bio、Terns Pharmaceuticals、Inventiva、Cirius Therapeutics、Enyo Pharma、Conatus Pharmaceuticals、吉利德科学、艾尔建诺华科学、艾尔建诺华

目录

第 1 章非酒精性脂肪性肝炎市场概述

  • 调查目的
  • 非酒精性脂肪性肝炎市场定义与研究范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章非酒精性脂肪性肝炎市场展望

  • 非酒精性脂肪性肝炎市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章非酒精性脂肪性肝炎市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买兴趣
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章非酒精性脂肪性肝炎市场规模

  • 非酒精性脂肪性肝炎市场规模（按价值）
  • 非酒精性脂肪性肝炎市场规模

7. 非酒精性脂肪性肝炎市场规模（依类型）

  • 市场概况
  • 生物标誌物
  • 治疗药物
  • 诊断剂
  • 其他的

8. 非酒精性脂肪性肝炎市场（依产品）

  • 市场概况
  • 製药
  • 生技药品
  • 营养补充品
  • 医疗设备
  • 其他的

9. 非酒精性脂肪性肝炎市场（依服务）

  • 市场概况
  • 临床试验
  • 咨询服务
  • 病人支援服务
  • 医药服务
  • 其他的

10. 非酒精性脂肪性肝炎市场（依技术）

  • 市场概况
  • 基因组学
  • 蛋白质体学
  • 生物资讯学
  • 成像技术
  • 其他的

第 11 章非酒精性脂肪性肝炎市场（依应用）

  • 市场概况
  • 切片检查
  • 影像检查
  • 血液检查
  • 其他的

第 12 章非酒精性脂肪性肝炎市场（依最终用户）

  • 市场概况
  • 医院
  • 诊所
  • 研究所
  • 製药公司
  • 其他的

第 13 章非酒精性脂肪性肝炎市场（依阶段）

  • 市场概况
  • 临床前试验
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 其他的

第 14 章非酒精性脂肪性肝炎市场（按模式）

  • 市场概况
  • 侵入性
  • 非侵入性
  • 其他的

15. 非酒精性脂肪性肝炎市场（依解决方案）

  • 市场概况
  • 治疗方案
  • 诊断解决方案
  • 其他的

16. 非酒精性脂肪性肝炎市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • Intercept Pharmaceuticals
  • Genfit
  • Madrigal Pharmaceuticals
  • Galmed Pharmaceuticals
  • Viking Therapeutics
  • Akero Therapeutics
  • 89bio
  • Terns Pharmaceuticals
  • Inventiva
  • Cirius Therapeutics
  • Enyo Pharma
  • Conatus Pharmaceuticals
  • Gilead Sciences
  • Allergan
  • Novartis
简介目录
Product Code: GIS34087

Non alcoholic Steatohepatitis Market is anticipated to expand from $11.9 billion in 2024 to $102.9 billion by 2034, growing at a CAGR of approximately 24.1%. The Non-Alcoholic Steatohepatitis (NASH) Market encompasses the development and commercialization of therapeutic solutions targeting liver inflammation and damage due to fat accumulation, excluding alcohol-related causes. This market is driven by rising obesity rates, sedentary lifestyles, and increasing awareness of liver health. It includes pharmaceuticals, diagnostics, and lifestyle interventions, with a focus on innovative therapies and early detection methods. As NASH can progress to cirrhosis or liver cancer, the demand for effective treatments is intensifying, fostering research and investment in this burgeoning field.

The Non-Alcoholic Steatohepatitis (NASH) Market is poised for robust expansion, driven by rising awareness and increasing prevalence. Within the treatment landscape, the therapeutics segment is expected to lead, with promising advancements in drug development. Specifically, the fibrosis treatment sub-segment is anticipated to be the top-performing area, as it addresses critical disease progression stages. Following closely, the diagnostic segment is gaining momentum, reflecting the need for early and accurate disease detection. Innovations in imaging techniques and biomarker identification are enhancing diagnostic capabilities, making non-invasive options more appealing. The lifestyle management sub-segment, focusing on dietary and exercise interventions, is also witnessing growth, as holistic approaches to managing NASH gain traction. Strategic collaborations and partnerships among pharmaceutical companies are accelerating research and development efforts, further propelling market dynamics. As the demand for effective NASH solutions intensifies, stakeholders are increasingly investing in novel therapeutic and diagnostic innovations.

Market Segmentation
TypeBiomarkers, Therapeutics, Diagnostics
ProductPharmaceuticals, Biologics, Nutraceuticals, Medical Devices
ServicesClinical Trials, Consulting Services, Patient Support Services, Regulatory Services
TechnologyGenomics, Proteomics, Bioinformatics, Imaging Technologies
ApplicationLiver Biopsy, Imaging Tests, Blood Tests
End UserHospitals, Clinics, Research Institutes, Pharmaceutical Companies
StagePreclinical, Phase I, Phase II, Phase III
ModeInvasive, Non-Invasive
SolutionsTherapeutic Solutions, Diagnostic Solutions

Market Snapshot:

The Non-Alcoholic Steatohepatitis (NASH) market is characterized by a dynamic landscape, with significant market share held by key pharmaceutical giants. Pricing strategies remain competitive, influenced by the high demand for innovative therapeutic solutions. Recent product launches have introduced groundbreaking treatments, enhancing the therapeutic arsenal available to healthcare providers. This has led to a competitive pricing environment, as companies vie for market dominance through differentiated product offerings and strategic partnerships. The market is witnessing a surge in research and development investments, driving the introduction of novel drug candidates. In terms of competition benchmarking, the NASH market is intensely competitive, with major players focusing on strategic mergers and acquisitions to bolster their market positions. Regulatory influences are pivotal, with stringent guidelines shaping the approval and commercialization of NASH therapies. The regulatory landscape in North America and Europe is particularly influential, setting high standards for clinical efficacy and safety. This regulatory rigor, coupled with increasing patient awareness, is driving the market's evolution. The competitive landscape is further intensified by emerging biotechnology firms, which are introducing innovative therapeutic approaches, thereby reshaping market dynamics.

Geographical Overview:

The Non-Alcoholic Steatohepatitis (NASH) market is witnessing varied growth across regions, each presenting unique opportunities. North America leads, driven by high obesity rates and rising awareness of liver diseases. The presence of key pharmaceutical companies investing in research and development further propels market growth. Europe follows, with increasing healthcare expenditure and a growing prevalence of lifestyle-related diseases enhancing market prospects. The Asia Pacific region is emerging rapidly, fueled by rising healthcare awareness and improving healthcare infrastructure. Countries like China and India are witnessing significant growth due to an increasing patient pool and government initiatives supporting liver disease research. Latin America shows potential, with Brazil and Mexico at the forefront, driven by lifestyle changes and improved healthcare access. The Middle East & Africa are nascent markets, with countries like Saudi Arabia recognizing the importance of addressing liver diseases, thus offering new growth pockets for NASH therapeutics.

Key Trends and Drivers:

The Non-Alcoholic Steatohepatitis (NASH) market is experiencing notable growth due to increasing prevalence of obesity and type 2 diabetes. These conditions are major risk factors for NASH, driving demand for effective treatments. A significant trend is the development of novel therapeutics targeting specific pathways involved in disease progression. Pharmaceutical companies are investing in research to discover innovative drugs that can halt or reverse liver damage. Rising awareness about liver health and early diagnosis is also propelling market growth. Healthcare providers are emphasizing the importance of screening and early intervention, leading to increased patient engagement. Additionally, advancements in diagnostic technologies are enabling more accurate and non-invasive methods for NASH detection. Regulatory support and expedited approval processes for promising therapies are further accelerating market expansion. The global focus on personalized medicine is creating opportunities for tailored treatment approaches, enhancing patient outcomes. As the understanding of NASH pathophysiology deepens, the market is poised for transformative advancements and lucrative opportunities.

Restraints and Challenges:

The Non-Alcoholic Steatohepatitis (NASH) market is confronted with several significant restraints and challenges. A primary challenge is the complexity of accurately diagnosing NASH, as it often requires invasive liver biopsies, which are both costly and risky for patients. This diagnostic complexity limits early detection and intervention, impeding market growth. Another constraint is the lack of approved therapies specifically targeting NASH, which results in a reliance on off-label treatments. This absence of targeted therapies limits treatment options and market expansion. Furthermore, the high cost of ongoing research and development poses a financial burden, deterring smaller companies from entering the market. The market also faces challenges due to the variability in disease progression among patients, complicating clinical trial designs and outcomes. Lastly, there is a general lack of awareness and understanding of NASH among both healthcare providers and patients, which hampers early diagnosis and treatment efforts, ultimately restraining market growth.

Key Players:

Intercept Pharmaceuticals, Genfit, Madrigal Pharmaceuticals, Galmed Pharmaceuticals, Viking Therapeutics, Akero Therapeutics, 89bio, Terns Pharmaceuticals, Inventiva, Cirius Therapeutics, Enyo Pharma, Conatus Pharmaceuticals, Gilead Sciences, Allergan, Novartis

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Non alcoholic Steatohepatitis Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Non alcoholic Steatohepatitis Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Stage
  • 2.10 Key Highlights of the Market, by Mode
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Stage
  • 3.9 Market Attractiveness Analysis, by Mode
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Non alcoholic Steatohepatitis Market Outlook

  • 4.1 Non alcoholic Steatohepatitis Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Non alcoholic Steatohepatitis Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Non alcoholic Steatohepatitis Market Size

  • 6.1 Non alcoholic Steatohepatitis Market Size, by Value
  • 6.2 Non alcoholic Steatohepatitis Market Size, by Volume

7: Non alcoholic Steatohepatitis Market, by Type

  • 7.1 Market Overview
  • 7.2 Biomarkers
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Diagnostics
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Non alcoholic Steatohepatitis Market, by Product

  • 8.1 Market Overview
  • 8.2 Pharmaceuticals
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Biologics
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Nutraceuticals
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Medical Devices
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Non alcoholic Steatohepatitis Market, by Services

  • 9.1 Market Overview
  • 9.2 Clinical Trials
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Consulting Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Patient Support Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Regulatory Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Non alcoholic Steatohepatitis Market, by Technology

  • 10.1 Market Overview
  • 10.2 Genomics
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Proteomics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Bioinformatics
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Imaging Technologies
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Non alcoholic Steatohepatitis Market, by Application

  • 11.1 Market Overview
  • 11.2 Liver Biopsy
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Imaging Tests
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Blood Tests
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Non alcoholic Steatohepatitis Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Clinics
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Pharmaceutical Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Non alcoholic Steatohepatitis Market, by Stage

  • 13.1 Market Overview
  • 13.2 Preclinical
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Phase I
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Phase II
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Phase III
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Non alcoholic Steatohepatitis Market, by Mode

  • 14.1 Market Overview
  • 14.2 Invasive
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Non-Invasive
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Non alcoholic Steatohepatitis Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Therapeutic Solutions
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Diagnostic Solutions
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Non alcoholic Steatohepatitis Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Stage
    • 16.2.9 North America Market Size and Forecast, by Mode
    • 16.2.10 North America Market Size and Forecast, by Solutions
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Stage
      • 16.2.9.8 United States Market Size and Forecast, by Mode
      • 16.2.9.9 United States Market Size and Forecast, by Solutions
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Stage
      • 16.2.10.8 Canada Market Size and Forecast, by Mode
      • 16.2.10.9 Canada Market Size and Forecast, by Solutions
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Stage
    • 16.3.9 Europe Market Size and Forecast, by Mode
    • 16.3.10 Europe Market Size and Forecast, by Solutions
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Mode
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Stage
      • 16.3.10.8 Germany Market Size and Forecast, by Mode
      • 16.3.10.9 Germany Market Size and Forecast, by Solutions
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Stage
      • 16.3.11.8 France Market Size and Forecast, by Mode
      • 16.3.11.9 France Market Size and Forecast, by Solutions
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Stage
      • 16.3.12.8 Spain Market Size and Forecast, by Mode
      • 16.3.12.9 Spain Market Size and Forecast, by Solutions
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Stage
      • 16.3.13.8 Italy Market Size and Forecast, by Mode
      • 16.3.13.9 Italy Market Size and Forecast, by Solutions
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.8 Netherlands Market Size and Forecast, by Mode
      • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Stage
      • 16.3.15.8 Sweden Market Size and Forecast, by Mode
      • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.8 Switzerland Market Size and Forecast, by Mode
      • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Stage
      • 16.3.17.8 Denmark Market Size and Forecast, by Mode
      • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Stage
      • 16.3.18.8 Finland Market Size and Forecast, by Mode
      • 16.3.18.9 Finland Market Size and Forecast, by Solutions
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Stage
      • 16.3.19.8 Russia Market Size and Forecast, by Mode
      • 16.3.19.9 Russia Market Size and Forecast, by Solutions
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Mode
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Stage
      • 16.4.9.8 China Market Size and Forecast, by Mode
      • 16.4.9.9 China Market Size and Forecast, by Solutions
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Stage
      • 16.4.10.8 India Market Size and Forecast, by Mode
      • 16.4.10.9 India Market Size and Forecast, by Solutions
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Stage
      • 16.4.11.8 Japan Market Size and Forecast, by Mode
      • 16.4.11.9 Japan Market Size and Forecast, by Solutions
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Stage
      • 16.4.12.8 South Korea Market Size and Forecast, by Mode
      • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Stage
      • 16.4.13.8 Australia Market Size and Forecast, by Mode
      • 16.4.13.9 Australia Market Size and Forecast, by Solutions
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Stage
      • 16.4.14.8 Singapore Market Size and Forecast, by Mode
      • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.8 Indonesia Market Size and Forecast, by Mode
      • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.8 Taiwan Market Size and Forecast, by Mode
      • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.8 Malaysia Market Size and Forecast, by Mode
      • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Stage
    • 16.5.9 Latin America Market Size and Forecast, by Mode
    • 16.5.10 Latin America Market Size and Forecast, by Solutions
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Stage
      • 16.5.9.8 Brazil Market Size and Forecast, by Mode
      • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Stage
      • 16.5.10.8 Mexico Market Size and Forecast, by Mode
      • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Stage
      • 16.5.11.8 Argentina Market Size and Forecast, by Mode
      • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Mode
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Mode
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Mode
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Stage
      • 16.6.10.8 UAE Market Size and Forecast, by Mode
      • 16.6.10.9 UAE Market Size and Forecast, by Solutions
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Stage
      • 16.6.11.8 South Africa Market Size and Forecast, by Mode
      • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Mode
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Intercept Pharmaceuticals
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Genfit
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Madrigal Pharmaceuticals
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Galmed Pharmaceuticals
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Viking Therapeutics
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Akero Therapeutics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 89bio
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Terns Pharmaceuticals
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Inventiva
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Cirius Therapeutics
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Enyo Pharma
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Conatus Pharmaceuticals
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Gilead Sciences
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Allergan
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Novartis
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis